Fresenius Medical Care Holdings, Inc. Sustainability Profile
Fresenius Medical Care Holdings, Inc., commonly referred to as Fresenius, is a leading global provider of products and services for individuals undergoing dialysis due to chronic kidney failure. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, delivering innovative healthcare solutions. Founded in 1996, Fresenius has achieved significant milestones, including the development of advanced dialysis technologies and comprehensive care services. The company’s core offerings include dialysis machines, dialysers, and a range of related services that enhance patient care and improve outcomes. Fresenius is recognised for its commitment to quality and innovation, positioning itself as a market leader in the renal care industry. With a strong focus on patient-centric solutions, Fresenius Medical Care continues to set benchmarks in healthcare excellence, making a profound impact on the lives of patients worldwide.
DitchCarbon Score
How does Fresenius Medical Care Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Medical Care Holdings, Inc.'s score of 51 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Medical Care Holdings, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Fresenius Medical Care AG, which may influence its climate commitments and emissions reporting. As part of its climate strategy, emissions data and reduction initiatives are cascaded from Fresenius Medical Care AG. However, there are no documented reduction targets or specific climate pledges available for Fresenius Medical Care Holdings, Inc. at this time. The absence of detailed emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own specific climate commitments or may rely on the overarching strategies of its parent organisation. Fresenius Medical Care AG, as the source of cascaded data, may have its own climate initiatives and targets, but these details are not specified for the subsidiary. The company operates within the healthcare sector, which is increasingly focusing on sustainability and carbon reduction, indicating a potential for future commitments in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000.0 |
| Scope 2 | 557,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000.0 |
How Carbon Intensive is Fresenius Medical Care Holdings, Inc.'s Industry?
How Carbon Intensive is Fresenius Medical Care Holdings, Inc.'s Location?
Fresenius Medical Care Holdings, Inc.'s Scope 3 Categories Breakdown
Fresenius Medical Care Holdings, Inc.'s Scope 3 emissions, which decreased by 100% last year and decreased by approximately 100% since 2023, demonstrating supply chain emissions tracking. Their carbon footprint includes supplier sustainability and value chain emissions data across Scope 3 categories, with "Purchased Goods and Services" being the largest emissions source at 17640922% of Scope 3 emissions.
Top Scope 3 Categories
Fresenius Medical Care Holdings, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fresenius Medical Care Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
